Inj Semaglutide 0.25mg, Inj Semaglutide 0.5mg, Inj Semaglutide 1.0mg, Inj Semaglutide 1.7mg, Inj Semaglutide 2.4mg, Inj Tirzepatide 2.5mg, 5.0mg, 10mg, 12.5mg in Multidose Prefilled Pen, Insulin Human Inhalation Powder (4,8,12 Units)
Indian Army · Pharmaceuticals · open
Key facts
- EMD: ₹4K
- Closing date: 17 Aug 2026
- Status: open
- Ministry: Ministry of Defence
- Department: Department of Military Affairs
Description
Tender for supply of various formulations of Semaglutide, Tirzepatide, and insulin inhalation powders, with a total quantity of 130 units, issued by the Indian Army under the Ministry of Defence, Department of Military Affairs. The bid validity is 180 days from the end date, with detailed technical specifications and EMD/ePBG requirements.
Eligibility & requirements
- Past performance: 30%
- Startup relaxation: No
- MSE relaxation: Yes
- Documents required: Experience certificate, Turnover certificate, OEM authorization
Commercial terms
- Bid type: Two Packet Bid
- Evaluation: item wise evaluation
- Make in India (MII): No
- MSE preference: Yes
Line items (12)
- Semaglutide 0.25mg — Qty: 130 unit
- Semaglutide 0.5mg — Qty: 130 unit
- Semaglutide 1.0mg — Qty: 130 unit
- Semaglutide 1.7mg — Qty: 130 unit
- Semaglutide 2.4mg — Qty: 130 unit
- Tirzepatide 2.5mg — Qty: 130 unit
- Tirzepatide 5.0mg — Qty: 130 unit
- Tirzepatide 10mg — Qty: 130 unit
- Tirzepatide 12.5mg — Qty: 130 unit
- Insulin Human Inhalation Powder 4 Units — Qty: 130 unit
- Insulin Human Inhalation Powder 8 Units — Qty: 130 unit
- Insulin Human Inhalation Powder 12 Units — Qty: 130 unit
1 tender document(s) available — sign up to download.